Skip to main content

Advertisement

SpringerLink
Log in

Safety of intra-articular transplantation of lentivirally transduced mesenchymal stromal cells for haemophilic arthropathy in a non-human primate

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Joint bleeding and resultant arthropathy are major determinants of quality of life in haemophilia patients. We previously developed a mesenchymal stromal cell (MSC)-based treatment approach for haemophilic arthropathy in a mouse model of haemophilia A. Here, we evaluated the long-term safety of intra-articular injection of lentivirally transduced autologous MSCs in non-human primates. Autologous bone-marrow-derived MSCs transduced with a lentiviral vector expressing coagulation factor VIII (FVIII) were injected into the left knee joint of cynomolgus monkeys. We first conducted codon optimization to increase FVIII production in the cells. Lentiviral transduction of autologous MSCs resulted in a significant increase of FVIII in the culture supernatant before transplantation. We did not find any tumour generation around the knee structure at 11–16 months after injection by magnetic resonance imaging. The proviral sequence of the simian immunodeficiency virus lentiviral vector was not detected in the heart, lungs, spleen, liver, testis, or bone marrow by real-time quantitative PCR. We confirmed the long-term safety of intra-articular injection of transduced MSCs in a non-human primate. The procedure may be an attractive therapeutic approach for joint diseases in haemophilia patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Young G. New challenges in hemophilia: long-term outcomes and complications. Hematol Am Soc Hematol Educ Program. 2012;2012:362–8.

    Google Scholar 

  2. Srivastava A. Haemophilia care—beyond the treatment guidelines. Haemophilia. 2014;20(Suppl 4):4–10.

    Article  PubMed  Google Scholar 

  3. Marijke van den Berg H. Preventing bleeds by treatment: new era for haemophilia changing the paradigm. Haemophilia. 2016;22(Suppl 5):9–13.

    Google Scholar 

  4. George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant. N Engl J Med. 2017;377:2215–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, et al. AAV5-factor VIII gene transfer in severe hemophilia A. N Engl J Med. 2017;377:2519–30.

    Article  PubMed  Google Scholar 

  6. Nijdam A, Foppen W, van der Schouw YT, Mauser-Bunschoten EP, Schutgens RE, Fischer K. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia. Haemophilia. 2016;22:852–8.

    Article  PubMed  CAS  Google Scholar 

  7. Hanley J, McKernan A, Creagh MD, Classey S, McLaughlin P, Goddard N, et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: a United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) guideline. Haemophilia. 2017;23:511–20.

    Article  PubMed  CAS  Google Scholar 

  8. Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017;115:192–9.

    Article  PubMed  CAS  Google Scholar 

  9. Ohmori T, Mizukami H, Ozawa K, Sakata Y, Nishimura S. New approaches to gene and cell therapy for hemophilia. J Thromb Haemost. 2015;13(Suppl 1):S133-42.

    PubMed  Google Scholar 

  10. Kashiwakura Y, Ohmori T, Mimuro J, Yasumoto A, Ishiwata A, Sakata A, et al. Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice. J Thromb Haemost. 2012;10:1802–13.

    Article  PubMed  CAS  Google Scholar 

  11. Ishiwata A, Mimuro J, Kashiwakura Y, Niimura M, Takano K, Ohmori T, et al. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene. Thromb Res. 2006;118:627–35.

    Article  PubMed  CAS  Google Scholar 

  12. Menzella HG. Comparison of two codon optimization strategies to enhance recombinant protein production in Escherichia coli. Microb Cell Fact. 2011;10:15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Mimuro J, Muramatsu S, Hakamada Y, Mori K, Kikuchi J, Urabe M, et al. Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter. Gene Ther. 2001;8:1690–7.

    Article  PubMed  CAS  Google Scholar 

  14. Ohmori T, Mimuro J, Takano K, Madoiwa S, Kashiwakura Y, Ishiwata A, et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy. FASEB J. 2006;20:1522–4.

    Article  PubMed  CAS  Google Scholar 

  15. McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, Raj D, et al. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood. 2013;121:3335–44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Ward NJ, Buckley SM, Waddington SN, Vandendriessche T, Chuah MK, Nathwani AC, et al. Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood. 2011;117:798–807.

    Article  PubMed  CAS  Google Scholar 

  17. Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev. 2011;9:CD003429.

    Google Scholar 

  18. Arruda VR, Doshi BS, Samelson-Jones BJ. Novel approaches to hemophilia therapy: successes and challenges. Blood. 2017;130:2251–6.

    Article  PubMed  CAS  Google Scholar 

  19. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–9.

    Article  PubMed  CAS  Google Scholar 

  20. McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;350:913–22.

    Article  PubMed  CAS  Google Scholar 

  21. Cavazzana M, Six E, Lagresle-Peyrou C, Andre-Schmutz I, Hacein-Bey-Abina S. Gene therapy for X-linked severe combined immunodeficiency: where do we stand? Hum Gene Ther. 2016;27:108–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Hematti P, Hong BK, Ferguson C, Adler R, Hanawa H, Sellers S, et al. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2004;2:e423.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol. 2006;24:687–96.

    Article  PubMed  CAS  Google Scholar 

  24. Alton EW, Beekman JM, Boyd AC, Brand J, Carlon MS, Connolly MM, et al. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax. 2017;72:137–47.

    Article  PubMed  Google Scholar 

  25. Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno R, Murakami Y, Murata T, et al. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates. Hum Gene Ther. 2009;20:943–54.

    Article  PubMed  CAS  Google Scholar 

  26. Ireland H, Gay MHP, Baldomero H, De Angelis B, Baharvand H, Lowdell MW, et al. The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015. Cytotherapy. 2018;20(1):1–20.

    Article  PubMed  Google Scholar 

  27. Porada CD, Sanada C, Kuo CJ, Colletti E, Mandeville W, Hasenau J, et al. Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. Exp Hematol. 2011;39:1124–35 e4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Sokal EM, Lombard CA, Roelants V, Najimi M, Varma S, Sargiacomo C, et al. Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia A patient. Transplantation. 2017;101:1845–51.

    Article  PubMed  Google Scholar 

  29. Kashiwakura Y, Mimuro J, Onishi A, Iwamoto M, Madoiwa S, Fuchimoto D, et al. Porcine model of hemophilia A. PLoS One. 2012;7:e49450.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge Dr. Hiroaki Shibata (Tsukuba Primate Research Center) for providing the protocol to isolate monkey MSCs.

Funding

This study was supported by the Research Program on HIV/AIDS from the Japan Agency for Medical Research and Development (AMED) under Grant Numbers JP17fk0410306h0003 and JP18fk0410017h0001.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Jichi Medical University School of Medicine, 3111-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Tsukasa Ohmori

  2. Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Hiroaki Mizukami

  3. The Corporation for Production and Research of Laboratory Primates, 1-16-2 Sakura, Tsukuba, Ibaraki, 305-0003, Japan

    Yuko Katakai

  4. Department of Radiology, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Sho Kawai, Hitoyasu Nakamura & Hideharu Sugimoto

  5. ID Pharma Inc., 6 Okubo, Tsukuba, Ibaraki, 300-2611, Japan

    Makoto Inoue & Tsugumine Shu

  6. Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Yoichi Sakata

Authors
  1. Tsukasa Ohmori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroaki Mizukami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuko Katakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sho Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hitoyasu Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makoto Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tsugumine Shu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hideharu Sugimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoichi Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsukasa Ohmori.

Ethics declarations

Conflict of interest

Dr Ohmori received research support from Bayer, Dai-ichi Sankyo, Novo Nordisk, and CSL Behring outside of this study. M.I. and T.T. are employees of ID Pharma Inc. All other authors declare no competing financial interests.

Electronic supplementary material

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ohmori, T., Mizukami, H., Katakai, Y. et al. Safety of intra-articular transplantation of lentivirally transduced mesenchymal stromal cells for haemophilic arthropathy in a non-human primate. Int J Hematol 108, 239–245 (2018). https://doi.org/10.1007/s12185-018-2465-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-2465-8

Keywords

Search

Navigation